NCT03783338

Brief Summary

Objective: To investigate the interaction effects of vitamin D supplementation and aerobic exercises on balance control and physical performance in children with Down syndrome (DS). Methods: Forty-five children with DS ranging in age from 8 to 12 years will be selected and will participate in this study. They will be assigned randomly using sealed envelopes into three equal groups (A, B and C). Group A will consist of 15 children and will receive the conventional physical therapy program (CPTP) only. Group B will consist of 15 children and will receive the CPTP plus the aerobic exercises. Group C also will consist of 15 children and will receive the CPTP, the aerobic exercises and Vitamin D supplementation in the form of an oral dose of vitamin D3 1000 IU (Cholecalciferol). The program of treatment will be 3 days/week for 12 weeks. Evaluation of balance by using the biodex balance system and physical performance by using the six-minute walk test (6MWT) will be conducted at baseline and after 12 weeks of the treatment program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 2, 2018

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

December 17, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 21, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2019

Completed
Last Updated

December 2, 2019

Status Verified

November 1, 2019

Enrollment Period

3 months

First QC Date

December 17, 2018

Last Update Submit

November 28, 2019

Conditions

Keywords

Aerobic exercisesBalanceDown syndromePhysical performanceVitamin D

Outcome Measures

Primary Outcomes (2)

  • Balance

    Balance assessment will be conducted by using the Biodex Stability System (BSS; Biodex, Inc, Shirley, NY) that enables objective assessment of balance.

    This outcome will be measured for each child before the beginning of treatment program and immediately after 12 weeks of the treatment program.

  • Physical performance

    Physical performance will be evaluated using the six-minute walk test (6MWT).

    This outcome will be measured for each child before the beginning of treatment program and immediately after 12 weeks of the treatment program.

Study Arms (3)

Physical therapy group

ACTIVE COMPARATOR

Group A will consist of 15 children and will receive the conventional physical therapy program only. This group will be used to compare the results of the other two groups.

Combination Product: Aerobic exercises and Vitamin D supplementation

Physical therapy and aerobic exercises group

EXPERIMENTAL

Group B will consist of 15 children and will receive the conventional physical therapy program and aerobic exercises.

Combination Product: Aerobic exercises and Vitamin D supplementation

Physical therapy, aerobic exercises and vitamin D group

EXPERIMENTAL

Group C will consist of 15 children and will receive the conventional physical therapy program, aerobic exercises and an oral daily dose of vitamin D3 1000 IU (Cholecalciferol) .

Combination Product: Aerobic exercises and Vitamin D supplementation

Interventions

Aerobic exercises: Children in groups B and C will receive aerobic exercises in the form of bicycle ergometer and treadmill training for 15 min 3 days/week for 12 weeks. The procedure and goals of exercise will be explained to all children before starting the exercise program. The child will stop exercising immediately if he feels pain, fainting or shortness of breath. Vitamin D supplementation: Children in group C only will receive vitamin D supplementation in the form of an oral daily dose of vitamin D3 1000 IU (Cholecalciferol) for 12 weeks.

Physical therapy and aerobic exercises groupPhysical therapy groupPhysical therapy, aerobic exercises and vitamin D group

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children with DS who can stand and walk independently
  • Children with 25 (OH) vitamin D levels of 16 ng/ml or less
  • Children who are not consuming estrogens, steroids or other medications that could interfere with vitamin D metabolism
  • The absence of visual and hearing impairments that could interfere with testing and training protocols
  • Children with mild intellectual disabilities and were capable of understanding visual and verbal instructions.

You may not qualify if:

  • Medical conditions that will severely limit a child's participation in the study as cardiac problems.
  • Musculoskeletal deformities of the lower limbs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy - Cairo University

Cairo, Giza Governorate, 12613, Egypt

Location

MeSH Terms

Conditions

Down Syndrome

Interventions

Exercise

Condition Hierarchy (Ancestors)

Intellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, Inborn

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcomes assessor will be blinded to which each child allocated to any one of the three arms.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Children will be assigned randomly using sealed envelopes into three intervention groups (A, B and C groups). Group A will receive the conventional physical therapy program (CPTP) only. Group B will receive the CPTP in addition to aerobic exercises, whereas group C will receive CPTP, aerobic exercises in addition to an oral daily dose of vitamin D3 1000 IU (Cholecalciferol). All groups will receive the treatment program for 12 weeks.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 17, 2018

First Posted

December 21, 2018

Study Start

December 2, 2018

Primary Completion

March 2, 2019

Study Completion

March 2, 2019

Last Updated

December 2, 2019

Record last verified: 2019-11

Locations